Fitzsimons NJ - Search Results

1

Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

Kang DE, Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ; SEARCH Database Study Group. Kang DE, et al. Among authors: fitzsimons nj. Urology. 2007 Aug;70(2):277-82. doi: 10.1016/j.urology.2007.03.059. Urology. 2007. PMID: 17826489 Free PMC article.

2

Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?

Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ. Fitzsimons NJ, et al. J Urol. 2006 Dec;176(6 Pt 1):2453-8; discussion 2458. doi: 10.1016/j.juro.2006.08.014. J Urol. 2006. PMID: 17085127

3

PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.

Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC Jr, Kane CJ, Terris MK, Aronson WJ, Amling CL. Freedland SJ, et al. Among authors: fitzsimons nj. Eur Urol. 2008 Apr;53(4):758-64; discussion 765-6. doi: 10.1016/j.eururo.2007.08.047. Epub 2007 Aug 31. Eur Urol. 2008. PMID: 17868976

4

A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database.

Fitzsimons NJ, Sun LL, Dahm P, Moul JW, Madden J, Gan TJ, Freedland SJ. Fitzsimons NJ, et al. Urology. 2007 Dec;70(6):1146-51. doi: 10.1016/j.urology.2007.07.065. Urology. 2007. PMID: 18158036

5

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.

Freedland SJ, Bañez LL, Sun LL, Fitzsimons NJ, Moul JW. Freedland SJ, et al. Among authors: fitzsimons nj. Prostate Cancer Prostatic Dis. 2009;12(3):259-63. doi: 10.1038/pcan.2009.11. Epub 2009 Jul 7. Prostate Cancer Prostatic Dis. 2009. PMID: 19581922

6

Prostate cancer screening and treatment recommendations.

Fitzsimons NJ, Freedland SJ. Fitzsimons NJ, et al. Virtual Mentor. 2006 May 1;8(5):323-6. doi: 10.1001/virtualmentor.2006.8.5.cprl1-0605. Virtual Mentor. 2006. PMID: 23232427 Free article. No abstract available.

7

Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.

Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Kang DE, et al. Among authors: fitzsimons nj. J Urol. 2007 Apr;177(4):1358-62; discussion 1362; quiz 1591. doi: 10.1016/j.juro.2006.11.058. J Urol. 2007. PMID: 17382731

8

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.

Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM. Moul JW, et al. Among authors: fitzsimons nj. J Urol. 2007 Feb;177(2):499-503; discussion 503-4. doi: 10.1016/j.juro.2006.09.063. J Urol. 2007. PMID: 17222618

9

Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.

Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ. Sun L, et al. BJU Int. 2007 Apr;99(4):753-7. doi: 10.1111/j.1464-410X.2006.06682.x. Epub 2007 Jan 19. BJU Int. 2007. PMID: 17244286

10

Medical technologies for the diagnosis of prostate cancer.

Fitzsimons NJ, Sun L, Moul JW. Fitzsimons NJ, et al. Expert Rev Med Devices. 2007 Mar;4(2):227-39. doi: 10.1586/17434440.4.2.227. Expert Rev Med Devices. 2007. PMID: 17359227 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters